Comparison
3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499 vs 3 4 Toe Cutaneous Syndactyly C5937396
Clinical comparison between 3 Methylcrotonyl Coa Carboxylase 2 Deficiency and 3 4 Toe Cutaneous Syndactyly for differential diagnosis and treatment planning.
3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499
A rare metabolic disorder affecting leucine breakdown. Infants may show developmental delay, seizures, and metabolic crises. Treatment involves biotin supplements and dietary protein restriction.
3 4 Toe Cutaneous Syndactyly C5937396
Skin webbing between the third and fourth toes, typically present at birth. Usually harmless and often left untreated unless it causes problems.
6 comparison axes
Onset
3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499
0-null
3 4 Toe Cutaneous Syndactyly C5937396
0-0
Onset patterns differ
Severity
3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499
severe
3 4 Toe Cutaneous Syndactyly C5937396
mild
Different severity levels
Chronic
3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499
Chronic
3 4 Toe Cutaneous Syndactyly C5937396
Chronic
Differing course
Communicable
3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499
No
3 4 Toe Cutaneous Syndactyly C5937396
No
Different transmission
Body System
3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499
metabolic
3 4 Toe Cutaneous Syndactyly C5937396
musculoskeletal
Same/different system
Category
3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499
metabolic
3 4 Toe Cutaneous Syndactyly C5937396
other
Different category
Bottom line
3-methylcrotonyl-coa-carboxylase-2-deficiency-C1859499 and 3-4-toe-cutaneous-syndactyly-C5937396 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499 | 3 4 Toe Cutaneous Syndactyly C5937396 | Discriminating power |
|---|---|---|---|
| System involved | Metabolic disorder of leucine breakdown; neurologic or crisis features may occur. | Localized musculoskeletal skin webbing of toes 3 and 4. | High |
| Onset and appearance | May become apparent in infancy; exact onset is not established here. | Typically visible at birth as toe webbing. | High |
| Functional impact | Potentially severe, with developmental delay, seizures, or metabolic decompensation. | Usually harmless and often needs no treatment. | High |
When to favor each condition
Choose 3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499 when
Infant with unexplained metabolic crisis or neurologic features
Leucine-pathway disorder belongs in the differential; confirmation requires clinician-directed testing.
Moderate
Abnormal newborn metabolic screening needing interpretation
An abnormal result is not a diagnosis and should be reviewed with metabolic specialists.
High
Family history or genetic concern for this enzyme deficiency
Targeted biochemical or genetic evaluation may be appropriate.
Moderate
Choose 3 4 Toe Cutaneous Syndactyly C5937396 when
Newborn with skin-only webbing between toes 3 and 4
The finding matches a localized congenital syndactyly phenotype.
High
No systemic, neurologic, or metabolic symptoms
Isolated mild toe webbing is usually a structural rather than metabolic problem.
Moderate
Cosmetic or footwear concern without functional limitation
Observation is often reasonable unless problems develop.
Moderate
How key tests differ
| Test | 3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499 | 3 4 Toe Cutaneous Syndactyly C5937396 | Interpretation |
|---|---|---|---|
| Physical examination | No specific external sign is established by these data. | Visible cutaneous connection between the third and fourth toes. | Exam strongly supports the toe finding but cannot diagnose the metabolic disorder. |
| Metabolic and genetic evaluation | Specialist testing may support impaired leucine metabolism; cutoffs are not provided. | Not routinely indicated for isolated toe webbing. | Abnormal results require clinician interpretation and do not by themselves prove diagnosis. |
| Imaging of the foot | No characteristic foot imaging finding is established. | May clarify soft-tissue versus bony involvement if clinically needed. | Imaging is optional and guided by function, not required for every mild case. |
Prognosis comparison
3 Methylcrotonyl Coa Carboxylase 2 Deficiency C1859499
- Outcome
- Variable and potentially serious; individual prognosis is not established by these data.
- Factors
- Age at recognition, metabolic stability, neurologic involvement, and specialist follow-up may matter.
3 4 Toe Cutaneous Syndactyly C5937396
- Outcome
- Usually favorable, with many cases left untreated.
- Factors
- Functional limitation, skin irritation, and personal preference influence care.
Time frame: The metabolic condition may require long-term follow-up; toe webbing is generally stable from birth.
Do not infer mortality or treatment response; clinician assessment is required.
Complications comparison
| Complication | Presentation |
|---|---|
| Metabolic decompensation | Crises are described as possible, especially in infants. Not a feature of isolated toe syndactyly. Triggers, frequency, and outcomes are not established here. |
| Neurologic effects | Developmental delay and seizures may occur. No neurologic complication is expected from skin webbing alone. These features are not definitive in every affected person. |
| Local foot problems | No specific foot complication is described. Possible irritation, footwear difficulty, or cosmetic concern. Many people remain asymptomatic and untreated. |
Patient education highlights
- HighDifferent conditions
One is a potentially serious metabolic disorder; the other is usually mild congenital toe webbing.
- HighTest results
An abnormal laboratory result is not the same as a confirmed diagnosis and needs clinician review.
- MediumWhen to seek care
Seek urgent care for poor feeding, lethargy, seizures, or suspected metabolic crisis; seek routine care for toe irritation or functional problems.